Form D · Other Health Care
Aletheia BioTherapeutics, LLC
New York, NY · CIK 0001765522
Offering snapshot reported Dec 2, 2024 · SEC filing
- Reported sold
- $5.14M Offering amount: $7.42M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 2, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 2, 2024 | Initial | $5,136,421 | No comparison | 19 | SEC filing |
| Nov 27, 2024 | Initial | $5,136,421 | No comparison | 19 | SEC filing |
| Aug 16, 2023 | Initial | $5,996,991 | No comparison | 18 | SEC filing |
| Jan 24, 2019 | Initial | $1,600,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-530883
Source: Form D, filed Dec 2, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Barton | Director |
| Chrystyna Bedrij | Executive |
| Michael Muhonen | Director |
| Laurie Platek | Director, Executive |
| Laurie Playtek | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
17 State Street, 3 Rd Floor Suite 350
New York, NY, 10004
New York, NY, 10004